Update, 3pm-- well, thanks to a quick return of my voicemail, we can correct this erroneous story forthwith: according to Schrader spokesman James Atkin, the story I just reported is NOT accurate, and in fact the opposite is true; Schrader opposes Med +5 in favor of a negotiated rates option ...